The reason I said focus on IMMUN is they've already secured funding for it and still have $19.5M to drawn-down so there's interesting in that technology, then start from scratch with that being their core product they are trying to bring to the market. At least positive trials will bring interest which could do a BIT type run.....
- Forums
- ASX - By Stock
- AVR
- Ann: Preliminary Final Report for period to 31 December 2018
Ann: Preliminary Final Report for period to 31 December 2018, page-20
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M |
Open | High | Low | Value | Volume |
$17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 191 | $17.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 191 | 17.150 |
1 | 1460 | 17.000 |
1 | 27 | 16.970 |
1 | 13 | 16.960 |
1 | 196 | 16.950 |
Price($) | Vol. | No. |
---|---|---|
17.500 | 500 | 1 |
17.750 | 2141 | 1 |
17.800 | 200 | 1 |
18.240 | 500 | 1 |
18.300 | 150 | 1 |
Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |